Magnesium for Muscle Spasms
Magnesium has limited to no benefit for common skeletal muscle cramps (such as nocturnal leg cramps in older adults), but it has specific, well-established roles in treating cardiac arrhythmias, tetanus-related spasms, and shivering after cardiac arrest. 1
Evidence-Based Applications
Where Magnesium IS Effective
Cardiac Arrhythmias (Ventricular Fibrillation/Tachycardia)
- Magnesium is recommended for VF/VT, particularly when associated with acute myocardial infarction, at a dose of 8 mmol bolus injection followed by 2.5 mmol/h infusion. 2
- For torsades de pointes with suspected hypomagnesemia, magnesium 8 mmol IV is recommended. 3
- In cardiac arrest with hypomagnesemia, 1-2 g IV magnesium sulfate bolus is indicated. 4
Tetanus-Related Muscle Spasms
- Magnesium sulfate is effective for controlling muscle spasms and rigidity in mild-to-moderate tetanus. 5
- Dosing: 100 mg/kg IV loading dose followed by continuous infusion at 40 mg/kg/hr, titrated upward by 5 mg/kg/hr every 6 hours until spasm control or loss of patellar reflex. 5
- In severe tetanus, magnesium significantly reduces the need for midazolam (p=0.026) and pipecuronium (p=0.005) to control spasms, though it does not reduce mechanical ventilation requirements. 6
- Magnesium can avoid the need for deep sedation and mechanical ventilation in moderate cases. 7
Post-Cardiac Arrest Shivering
- Magnesium sulfate infusions provide modest adjunctive benefit for shivering suppression during targeted temperature management, though effects are slight and typically insufficient when used alone. 2
- Should be combined with other non-sedating adjuncts like acetaminophen due to limited efficacy as monotherapy. 2
- Safe with serum levels maintained below 4 mg/dL. 2
Where Magnesium IS NOT Effective
Idiopathic Skeletal Muscle Cramps (Nocturnal Leg Cramps)
- For older adults with idiopathic rest cramps, magnesium provides no clinically meaningful benefit compared to placebo. 1
- At 4 weeks, the percentage change in cramp frequency showed no significant difference (MD -9.59%, 95% CI -23.14% to 3.97%). 1
- No difference in cramp intensity (RR 1.33 for moderate/severe cramps, 95% CI 0.81 to 2.21). 1
- No difference in cramp duration (RR 1.83 for cramps ≥1 minute, 95% CI 0.74 to 4.53). 1
- This represents moderate-to-high certainty evidence against routine use. 1
Pregnancy-Associated Leg Cramps
- Evidence is conflicting and inconclusive—some studies show benefit while others show none. 1
- Cannot make a firm recommendation for or against use in this population. 1
Cerebral Vasospasm After Subarachnoid Hemorrhage
- Magnesium sulfate does NOT improve clinical outcomes in aneurysmal subarachnoid hemorrhage despite early promising data. 2
- The phase 3 IMASH trial showed no clinical benefit from magnesium infusion over placebo. 2
- While pilot trials suggested reduction in delayed ischemic deficits, meta-analysis did not confirm benefit. 2
Erythromelalgia
- Oral magnesium (600-6500 mg daily) showed improvement in 8 of 13 patients in one survey, but evidence is extremely limited. 2
- IV magnesium 2 g every 2-3 weeks has minimal supporting data. 2
Muscle Cramps in Liver Cirrhosis
- Hypomagnesemia correction may help, but specific evidence for magnesium supplementation in cirrhosis-related cramps is limited to one small inconclusive study. 2, 1
- Baclofen (10-30 mg/day) and albumin (20-40 g/week) are preferred for muscle cramps in cirrhosis. 2
Safety Profile
Adverse Events
- Minor adverse events occur more frequently with magnesium than placebo (RR 1.51,95% CI 0.98 to 2.33), primarily gastrointestinal (diarrhea in 11-37% vs 10-14% in controls). 1
- Major adverse events and withdrawals due to adverse effects are not significantly different from placebo. 1
- Asymptomatic hypocalcemia is common with magnesium therapy and requires calcium supplementation. 5
Monitoring Requirements
- When using continuous magnesium infusions for tetanus or other spastic conditions, monitor cardiovascular and respiratory function, deep tendon reflexes, and serum magnesium concentrations closely. 7
- Have calcium chloride 10% (5-10 mL) or calcium gluconate 10% (15-30 mL) available to reverse potential magnesium toxicity. 4
- Target serum magnesium above 1.3 mEq/L (normal range 1.3-2.2 mEq/L). 4
Clinical Algorithm
For common muscle cramps (nocturnal leg cramps in older adults):
- Do NOT use magnesium as it provides no meaningful benefit. 1
- Consider alternative therapies based on underlying etiology.
For cardiac arrhythmias (VF/VT, torsades):
- Use magnesium 8 mmol IV bolus followed by 2.5 mmol/h infusion. 2
For tetanus-related spasms:
- Start magnesium 100 mg/kg IV load, then 40 mg/kg/hr infusion, titrating upward every 6 hours. 5
- Expect efficacy in mild-moderate cases; severe cases will likely require additional sedation. 5
For post-cardiac arrest shivering:
- Use magnesium as adjunct only, combined with acetaminophen and other measures. 2